SOLANA CO (HSDT) Fundamental Analysis & Valuation
NASDAQ:HSDT • US42328V8761
Current stock price
2.04 USD
-0.07 (-3.32%)
At close:
2.0353 USD
0 (-0.23%)
After Hours:
This HSDT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HSDT Profitability Analysis
1.1 Basic Checks
- In the past year HSDT has reported negative net income.
- In the past year HSDT has reported a negative cash flow from operations.
- HSDT had negative earnings in each of the past 5 years.
- In the past 5 years HSDT always reported negative operating cash flow.
1.2 Ratios
- The Return On Assets of HSDT (-77.82%) is worse than 76.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -77.82% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-175.99%
ROA(5y)-174.45%
ROE(3y)-552.67%
ROE(5y)-436.83%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- HSDT's Gross Margin of 49.63% is in line compared to the rest of the industry. HSDT outperforms 44.57% of its industry peers.
- The Profit Margin and Operating Margin are not available for HSDT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 49.63% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. HSDT Health Analysis
2.1 Basic Checks
- HSDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- HSDT has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for HSDT has been increased compared to 5 years ago.
- There is no outstanding debt for HSDT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -1.27, we must say that HSDT is in the distress zone and has some risk of bankruptcy.
- HSDT's Altman-Z score of -1.27 is on the low side compared to the rest of the industry. HSDT is outperformed by 61.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.27 |
ROIC/WACCN/A
WACC10.28%
2.3 Liquidity
- HSDT has a Current Ratio of 40.03. This indicates that HSDT is financially healthy and has no problem in meeting its short term obligations.
- HSDT's Current ratio of 40.03 is amongst the best of the industry. HSDT outperforms 100.00% of its industry peers.
- A Quick Ratio of 39.67 indicates that HSDT has no problem at all paying its short term obligations.
- The Quick ratio of HSDT (39.67) is better than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 40.03 | ||
| Quick Ratio | 39.67 |
3. HSDT Growth Analysis
3.1 Past
- HSDT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.97%, which is quite impressive.
- The Revenue has grown by 87.45% in the past year. This is a very strong growth!
- HSDT shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -19.09% yearly.
EPS 1Y (TTM)73.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.81%
Revenue 1Y (TTM)87.45%
Revenue growth 3Y0%
Revenue growth 5Y-19.09%
Sales Q2Q%1266.67%
3.2 Future
- The Earnings Per Share is expected to grow by 40.88% on average over the next years. This is a very strong growth
- HSDT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 177.16% yearly.
EPS Next Y93.98%
EPS Next 2Y40.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-20.09%
Revenue Next 2Y18.3%
Revenue Next 3Y346.25%
Revenue Next 5Y177.16%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. HSDT Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for HSDT. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HSDT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- HSDT's earnings are expected to grow with 40.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.88%
EPS Next 3YN/A
5. HSDT Dividend Analysis
5.1 Amount
- No dividends for HSDT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
HSDT Fundamentals: All Metrics, Ratios and Statistics
2.04
-0.07 (-3.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-18 2025-11-18/amc
Earnings (Next)03-23 2026-03-23/amc
Inst Owners20.55%
Inst Owner Change7.3%
Ins Owners0.02%
Ins Owner Change0%
Market Cap107.71M
Revenue(TTM)941.00K
Net Income(TTM)-370.37M
Analysts43.33
Price TargetN/A
Short Float %2.44%
Short Ratio2.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)89.81%
Min EPS beat(2)39.17%
Max EPS beat(2)140.46%
EPS beat(4)3
Avg EPS beat(4)46.76%
Min EPS beat(4)-6.38%
Max EPS beat(4)140.46%
EPS beat(8)6
Avg EPS beat(8)31.72%
EPS beat(12)9
Avg EPS beat(12)25.44%
EPS beat(16)12
Avg EPS beat(16)24.74%
Revenue beat(2)1
Avg Revenue beat(2)238.71%
Min Revenue beat(2)-43.79%
Max Revenue beat(2)521.21%
Revenue beat(4)2
Avg Revenue beat(4)118.62%
Min Revenue beat(4)-51.96%
Max Revenue beat(4)521.21%
Revenue beat(8)4
Avg Revenue beat(8)47.69%
Revenue beat(12)6
Avg Revenue beat(12)25.05%
Revenue beat(16)9
Avg Revenue beat(16)26.35%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 114.47 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1206.39
EYN/A
EPS(NY)-65.79
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.02
BVpS-2.89
TBVpS-2.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -77.82% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 49.63% | ||
| FCFM | N/A |
ROA(3y)-175.99%
ROA(5y)-174.45%
ROE(3y)-552.67%
ROE(5y)-436.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 40.03 | ||
| Quick Ratio | 39.67 | ||
| Altman-Z | -1.27 |
F-Score5
WACC10.28%
ROIC/WACCN/A
Cap/Depr(3y)10.97%
Cap/Depr(5y)13.37%
Cap/Sales(3y)2.54%
Cap/Sales(5y)5.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.81%
EPS Next Y93.98%
EPS Next 2Y40.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)87.45%
Revenue growth 3Y0%
Revenue growth 5Y-19.09%
Sales Q2Q%1266.67%
Revenue Next Year-20.09%
Revenue Next 2Y18.3%
Revenue Next 3Y346.25%
Revenue Next 5Y177.16%
EBIT growth 1Y-18.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6%
OCF growth 3YN/A
OCF growth 5YN/A
SOLANA CO / HSDT Fundamental Analysis FAQ
What is the fundamental rating for HSDT stock?
ChartMill assigns a fundamental rating of 2 / 10 to HSDT.
What is the valuation status of SOLANA CO (HSDT) stock?
ChartMill assigns a valuation rating of 1 / 10 to SOLANA CO (HSDT). This can be considered as Overvalued.
What is the profitability of HSDT stock?
SOLANA CO (HSDT) has a profitability rating of 0 / 10.
How financially healthy is SOLANA CO?
The financial health rating of SOLANA CO (HSDT) is 4 / 10.